证券代码：301319 证券简称：唯特偶 公告编号：2025-055 深圳市唯特偶新材料股份有限公司 关于注销部分股票期权的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 深圳市唯特偶新材料股份有限公司（以下简称"公司"）于 2025 年 10 月 27 日召开的第六届董事会第七次会议和第六届董事会薪酬与考核委员会第三次 会议审议通过了《关于注销部分股票期权的议案》，具体内容如下： 一、公司 2024 年股票期权激励计划概述 1、2024 年 3 月 20 日，公司召开第五届董事会第十五次会议，审议通过了 《关于〈公司 2024 年股票期权激励计划（草案）〉及其摘要的议案》《关于〈公 司 2024 年股票期权激励计划实施考核管理办法〉的议案》《关于提请公司股东 大会授权董事会办理 2024 年股票期权激励计划相关事宜的议案》《关于召开公 司 2024 年第二次临时股东大会的议案》，律师等中介机构出具了相应报告。 2、2024 年 3 月 20 日，公司召开第五届监事会第九次会议，审议通过了《关 于〈公司 2024 年股票期权激励计划（草案）〉及其摘要的议 ...

唯特偶公告，第三季度营收为3.96亿元，同比增长19.67%；净利润为2735.17万元，同比增长15.98%。 前三季度营收为10.6亿元，同比增长24.00%；净利润为6953.45万元，同比下降4.84%。 ...

国金证券股份有限公司 关于深圳市唯特偶新材料股份有限公司开展期货套 期保值业务的核查意见 国金证券股份有限公司（以下简称"国金证券"或"保荐机构"）作为深圳市唯 特偶新材料股份有限公司（以下简称"唯特偶"或"公司"）首次公开发行股票并在 创业板上市及持续督导的保荐机构，根据《证券发行上市保荐业务管理办法》《深 圳证券交易所创业板股票上市规则（2025 年修订）》《深圳证券交易所上市公司 自律监管指引第 2 号——创业板上市公司规范运作（2025 年修订）》《深圳证券 交易所上市公司自律监管指引第 13 号——保荐业务》等有关法律法规的规定， 对唯特偶开展期货套期保值业务事项进行了审慎核查并出具本核查意见如下： 一、开展期货套期保值业务的目的 为充分利用期货套期保值功能，合理降低主要原材料及产成品价格波动风险， 降低价格波动对生产经营的影响，提升风险抵御能力，增强财务稳健性，公司计 划开展期货套期保值业务。 二、开展期货套期保值业务的基本情况 （一）涉及业务品种 本次公司套期保值期货品种限于在场内市场交易的与公司生产经营有直接 关系的大宗原材料（包括但不限于锡、白银等），严禁进行以逐利为目的的任何 投机交易。 ...

广东华商律师事务所 关于 深圳市唯特偶新材料股份有限公司 注销部分股票期权 的 法律意见书 二〇二五年十月 深圳市福田区深南大道 4011 号香港中旅大厦 21-26 层 21-26/F, HKCTS Tower, 4011 Shennan Road, Futian District, Shenzhen, PRC 电话(Tel)：0086-755-83025555 传真(Fax)：0086-755-83025068 邮政编码(P.C.)：518000 网址 http://www.huashang.cn 法律意见书 广东华商律师事务所 关于深圳市唯特偶新材料股份有限公司 注销部分股票期权的 法律意见书 致：深圳市唯特偶新材料股份有限公司 广东华商律师事务所（以下简称"本所"）接受深圳市唯特偶新材料股份有 限公司（以下简称"公司"或"唯特偶"）的委托，担任公司 2024 年股票期权 激励计划项目（以下简称"本次激励计划"）的专项法律顾问。本所律师根据《中 华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》 （以下简称"《证券法》"）、《上市公司股权激励管理办法》（以下简称"《管 理办法》"） ...

关于深圳市唯特偶新材料股份有限公司及其子公司 使用部分闲置募集资金及自有资金进行现金管理的核查意见 国金证券股份有限公司（以下简称"国金证券"或"保荐机构"）作为深圳市唯 特偶新材料股份有限公司（以下简称"唯特偶"或"公司"）首次公开发行股票并在 创业板上市及持续督导的保荐机构，根据《证券发行上市保荐业务管理办法》《上 市公司募集资金监管规则》《深圳证券交易所创业板股票上市规则（2025 年修订）》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作 （2025 年修订）》等有关法律法规的规定，对公司及子公司使用部分闲置募集资 金进行现金管理及自有资金进行现金管理进行了核查，具体核查情况如下： 一、募集资金的基本情况 经中国证监会出具的《关于同意深圳市唯特偶新材料股份有限公司首次公开 发行股票注册的批复》（证监许可[2022]1259 号）核准，并经深圳证券交易所同 意，公司首次向社会公众公开发行人民币普通股（A 股）1,466 万股，每股面值 人民币 1.00 元，发行价格为 47.75 元/股，募集资金总额为人民币 70,001.50 万元， 扣除相关发行费用后实际募集资金净额为人民 ...

Financial Performance - The company's revenue for Q3 2025 reached ¥396,064,947.15, representing a year-over-year increase of 19.67%[5] - Net profit attributable to shareholders was ¥27,351,709.00, up 15.98% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was ¥24,889,934.07, reflecting a 25.42% increase year-over-year[5] - Revenue for the first nine months of 2025 was ¥1,060,497,798.57, a 24.00% increase compared to the same period in 2024[10] - Total operating revenue for the current period reached ¥1,060,497,798.57, an increase of 24% compared to ¥855,227,351.73 in the previous period[19] - Net profit for the current period was ¥69,294,219.56, a decrease of 5.3% from ¥73,067,610.95 in the previous period[19] Cash Flow and Liquidity - The operating cash flow net amount for the year-to-date period was ¥81,607,205.51, showing a significant increase of 1,578.59%[5] - Cash generated from operating activities was ¥948,567,463.11, an increase from ¥696,310,970.57 in the prior period[22] - Net cash flow from operating activities amounted to ¥81,607,205.51, a significant increase from ¥4,861,653.75 in the previous period, reflecting improved operational efficiency[23] - Total cash inflow from investment activities reached ¥1,431,484,085.27, compared to ¥937,541,024.36 in the prior period, indicating a strong investment recovery[23] - Cash outflow from investment activities was ¥1,499,225,150.58, up from ¥1,055,422,876.50, leading to a net cash flow from investment activities of -¥67,741,065.31, an improvement from -¥117,881,852.14[23] - Cash flow from financing activities resulted in a net outflow of -¥42,425,845.01, compared to -¥77,489,729.49 previously, showing a reduction in financing pressure[24] - The ending balance of cash and cash equivalents was ¥115,645,953.29, down from ¥187,746,593.74, reflecting a decrease in liquidity[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,532,439,332.63, an increase of 10.69% from the end of the previous year[5] - The company's total current assets amount to 1,403,345,726.22 CNY, an increase from 1,258,918,389.36 CNY at the beginning of the period[16] - The total assets of the company are 1,532,439,332.63 CNY, up from 1,384,401,563.46 CNY at the beginning of the period[16] - The company's total liabilities increased to ¥359,017,488.20, compared to ¥240,524,647.29 in the previous period, reflecting a growth of 49.2%[19] - The total amount of current liabilities rose to ¥356,298,256.94, compared to ¥237,161,014.15 in the previous period, marking a 50.2% increase[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 8,929[11] - The largest shareholder, Liao Gaobing, holds 30.44% of shares, totaling 37,842,562 shares[11] - The company has a total of 36,835,058 shares that have had their restrictions lifted during the reporting period[13] - The total number of restricted shares at the end of the period is 30,911,433[13] Research and Development - Research and development expenses for the first nine months of 2025 were ¥28,150,532.61, reflecting a 19.86% increase year-over-year[10] - The company reported a decrease in research and development expenses to ¥28,150,532.61 from ¥23,486,640.11, reflecting a growth of 19.5%[19] Other Financial Metrics - The company's basic earnings per share for Q3 2025 was ¥0.2205, a 15.28% increase year-over-year[5] - Basic earnings per share for the current period was ¥0.5628, down from ¥0.5926 in the previous period[20] - The weighted average return on equity was 2.38%, an increase of 0.30 percentage points compared to the previous year[5] - The company's goodwill increased to 940,613.05 CNY from 264,082.80 CNY[16] Audit and Investor Confidence - The company did not undergo an audit for the third quarter financial report, which may impact investor confidence[25]

Group 1 - On October 20, a total of 8 companies were investigated by institutions, with 6 companies being surveyed by funds, highlighting a significant interest in Huabang Health, which attracted 13 funds for the investigation [1][2] - The companies surveyed include 3 from the main board and 3 from the ChiNext board, indicating a diverse representation across different market segments [2] - Among the surveyed companies, only one has a total market capitalization exceeding 50 billion yuan, while four companies have market capitalizations below 10 billion yuan, including Boin Special Welding, Weiteou, and Zhonglai Shares [2] Group 2 - In terms of market performance, two stocks among the surveyed companies have increased in the last five days, with Boin Special Welding and Huabang Health showing gains of 27.01% and 8.39% respectively [2] - Conversely, four stocks have experienced declines, with Weiteou, Zhonglai Shares, and Guangdian Yuntong showing decreases of 7.24%, 1.83%, and 1.55% respectively [2] - Fund inflows over the past five days indicate that Huabang Health received a net inflow of 177 million yuan, the highest among the surveyed stocks, followed by Boin Special Welding and Guangdian Yuntong with net inflows of 130 million yuan and 399,700 yuan respectively [2] Group 3 - Among the surveyed companies, only one has released its third-quarter report, with Cangge Mining reporting the highest year-on-year net profit growth of 47.26% [2]

Core Viewpoint - The company predicts that tin prices will likely remain in a range-bound fluctuation due to mixed macroeconomic factors and supply-demand dynamics [1] Group 1: Macroeconomic Factors - There is an increasing expectation of interest rate cuts by the Federal Reserve [1] - Ongoing trade tensions between China and the U.S. contribute to cautious market sentiment [1] Group 2: Supply Dynamics - Domestic large smelters in China are expected to resume tin ingot production in October [1] - However, raw material supply remains tight, providing support for supply [1] Group 3: Demand Dynamics - Demand appears weak, with no improvement in orders noted [1] - Downstream inventory replenishment is cautious due to high tin prices, resulting in limited transactions [1]

Group 1: Business Strategy and Development - The company has successfully transitioned from a single product line in electronic assembly materials to a dual focus on electronic assembly materials and reliability materials, establishing a comprehensive product matrix [2][3] - The reliability materials segment emphasizes three technical dimensions: mechanics, corrosion resistance, and thermal properties, targeting core categories like electronic adhesives and protective coatings [3][4] Group 2: Global Expansion and Market Presence - The company has established subsidiaries in regions including Hong Kong, Singapore, the USA, Vietnam, Thailand, and Mexico, enhancing local production capabilities [4] - Currently, overseas revenue accounts for only 1.38% of total revenue, but there has been a 40.84% growth in overseas business in 2024, indicating potential for future expansion [5] Group 3: Raw Material Management and Pricing Strategy - The company has implemented a multi-layered response mechanism to manage raw material price fluctuations, including long-term partnerships with major tin mining companies and a product pricing mechanism linked to raw material costs [6] - Current market conditions suggest that tin prices may remain volatile, influenced by both supply constraints and weak demand [5][6] Group 4: Future Planning and Innovation - The company aims to focus on five key areas for growth in the second half of the year: R&D innovation, talent supply chain, global market expansion, international production capacity, and capital operations [7] - The company is committed to enhancing domestic substitution efforts, with core products achieving performance levels comparable to international standards, thereby increasing market share in critical sectors like semiconductors and automotive electronics [8]

Core Viewpoint - The company reported a decrease in the number of shareholders and a decline in stock price, alongside mixed financial performance in the recent half-year report [1] Group 1: Shareholder and Stock Performance - As of October 10, the number of shareholders for the company was 8,041, a decrease of 888 from the previous period (September 30), representing a decline of 9.95% [1] - The closing price of the company's stock was 41.40 yuan, down 3.86%, with a cumulative decline of 11.73% since the concentration of shares began [1] - The stock experienced 2 days of increase and 5 days of decrease during the reporting period [1] Group 2: Financing and Margin Data - As of October 16, the latest margin trading balance for the stock was 149 million yuan, with the financing balance also at 149 million yuan [1] - The financing balance decreased by 5.55 million yuan during the concentration period, reflecting a decline of 3.60% [1] Group 3: Financial Performance - In the first half of the year, the company achieved operating revenue of 664 million yuan, representing a year-on-year growth of 26.74% [1] - The net profit for the same period was 42.18 million yuan, showing a year-on-year decline of 14.76% [1] - The basic earnings per share were 0.3421 yuan, with a weighted average return on equity of 3.65% [1]